New Omicron sub-variants better at evading vaccine and antibody treatments, reveals study
July 06, 2022 13:20 ISTIn addition, the scientists tested the ability of 19 monoclonal antibody treatments to neutralise the variants and found that only one of the available antibody treatments remained highly effective against both Omicron sub-variants BA.2.12.1 and BA.4/5.